These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24861820)

  • 41. Destination therapy with left ventricular assist devices: patient selection and outcomes.
    Slaughter MS; Meyer AL; Birks EJ
    Curr Opin Cardiol; 2011 May; 26(3):232-6. PubMed ID: 21430527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between renal function and left ventricular assist device use.
    Butler J; Geisberg C; Howser R; Portner PM; Rogers JG; Deng MC; Pierson RN
    Ann Thorac Surg; 2006 May; 81(5):1745-51. PubMed ID: 16631666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk stratification in patients with advanced heart failure requiring biventricular assist device support as a bridge to cardiac transplantation.
    Cheng RK; Deng MC; Tseng CH; Shemin RJ; Kubak BM; MacLellan WR
    J Heart Lung Transplant; 2012 Aug; 31(8):831-8. PubMed ID: 22759799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients.
    Ochiai Y; McCarthy PM; Smedira NG; Banbury MK; Navia JL; Feng J; Hsu AP; Yeager ML; Buda T; Hoercher KJ; Howard MW; Takagaki M; Doi K; Fukamachi K
    Circulation; 2002 Sep; 106(12 Suppl 1):I198-202. PubMed ID: 12354733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
    Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
    J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation.
    Deo SV; Daly RC; Altarabsheh SE; Hasin T; Zhao Y; Shah IK; Stulak JM; Boilson BA; Schirger JA; Joyce LD; Park SJ
    ASAIO J; 2013; 59(1):57-62. PubMed ID: 23263341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients.
    Mikus E; Stepanenko A; Krabatsch T; Loforte A; Dandel M; Lehmkuhl HB; Hetzer R; Potapov EV
    Eur J Cardiothorac Surg; 2011 Oct; 40(4):971-7. PubMed ID: 21354812
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The value of Stanford integrated psychosocial assessment for transplantation (SIPAT) in prediction of clinical outcomes following left ventricular assist device (LVAD) implantation.
    Bui QM; Braun OO; Brambatti M; Gernhofer YK; Hernandez H; Pretorius V; Adler E
    Heart Lung; 2019; 48(2):85-89. PubMed ID: 30227993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ventricular assist devices as destination therapy: psychosocial and ethical implications.
    Grogan S; Kostick K; Delgado E; Bruce CR
    Methodist Debakey Cardiovasc J; 2015; 11(1):9-11. PubMed ID: 25793023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Caregivers and Left Ventricular Assist Devices as a Destination, Not a Journey.
    Kirkpatrick JN; Kellom K; Hull SC; Henderson R; Singh J; Coyle LA; Mountis M; Shore ED; Petrucci R; Cronholm PF; Barg FK
    J Card Fail; 2015 Oct; 21(10):806-15. PubMed ID: 26070494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renal function and outcome after continuous flow left ventricular assist device implantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Grimm M; Wolner E; Wieselthaler GM
    Ann Thorac Surg; 2009 Apr; 87(4):1072-8. PubMed ID: 19324130
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Zuckermann AO; Wieselthaler GM
    J Heart Lung Transplant; 2009 Apr; 28(4):367-72. PubMed ID: 19332264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Destination therapy with left ventricular assist devices: for whom and when?
    Porepa LF; Starling RC
    Can J Cardiol; 2014 Mar; 30(3):296-303. PubMed ID: 24565254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of changes in health status between and within patients 12 months post left ventricular assist device implantation.
    Brouwers C; de Jonge N; Caliskan K; Manintveld O; Young QR; Kaan A; Kealy J; Denollet J; Pedersen SS
    Eur J Heart Fail; 2014 May; 16(5):566-73. PubMed ID: 24619799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension.
    Kutty RS; Parameshwar J; Lewis C; Catarino PA; Sudarshan CD; Jenkins DP; Dunning JJ; Tsui SS
    Eur J Cardiothorac Surg; 2013 Jun; 43(6):1237-42. PubMed ID: 23345184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Granulomatous myocarditis in severe heart failure patients undergoing implantation of a left ventricular assist device.
    Segura AM; Radovancevic R; Demirozu ZT; Frazier OH; Buja LM
    Cardiovasc Pathol; 2014; 23(1):17-20. PubMed ID: 23928368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
    J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.
    Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS
    ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A contemporary review of mechanical circulatory support.
    Patel CB; Cowger JA; Zuckermann A
    J Heart Lung Transplant; 2014 Jul; 33(7):667-74. PubMed ID: 24721183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.